Logo image
Maternal Microvascular Dysfunction During and After Preeclamptic Pregnancy
Journal article   Open access

Maternal Microvascular Dysfunction During and After Preeclamptic Pregnancy

Kelsey S Schwartz and Anna E Stanhewicz
Comprehensive Physiology, Vol.14(4), pp.5703-5727
10/09/2024
DOI: 10.1002/cphy.c240003
PMCID: PMC12974215
PMID: 39382165
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC12974215/View
Open Access

Abstract

Preeclampsia, a pregnancy disorder characterized by de novo hypertension and maternal multisystem organ dysfunction, is the leading cause of maternal mortality worldwide and is associated with a fourfold greater risk of cardiovascular disease throughout the lifespan. Current understanding of the etiology of preeclampsia remains unclear, due in part to the varying phenotypical presentations of the disease, which has hindered the development of effective and mechanism-specific treatment or prevention strategies both during and after the affected pregnancy. These maternal sequelae of preeclampsia are symptoms of systemic vascular dysfunction in the maternal nonreproductive microvascular beds that drives the development and progression of adverse cardiovascular outcomes during preeclampsia. Despite normalization of vascular disturbances after delivery, subclinical dysfunction persists in the nonreproductive microvascular beds, contributing to an increased lifetime risk of cardiovascular and metabolic diseases and all-cause mortality. Given that women with a history of preeclampsia demonstrate vascular dysfunction despite an absence of traditional CVD risk factors, an understanding of the underlying mechanisms of microvascular dysfunction during and after preeclampsia is essential to identify potential therapeutic avenues to mitigate or reverse the development of overt disease. This article aims to provide a summary of the existing literature on the pathophysiology of maternal microvascular dysfunction during preeclampsia, the mechanisms underlying the residual dysfunction that remains after delivery, and current and potential treatments both during and after the affected pregnancy that may reduce microvascular dysfunction in these high-risk women. © 2024 American Physiological Society. Compr Physiol 14:5703-5727, 2024.
Pregnancy Animals Female Humans Microcirculation - physiology Microvessels - physiopathology Pre-Eclampsia - etiology Pre-Eclampsia - physiopathology

Details

Metrics

Logo image